Orexigen Therapeutics Inc (NASDAQ:OREX)

Delayed Data
As of Feb 16
 +0.0125 / +1.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +321.69% increase from the last price of 0.83.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -52.59%
Growthannually -412.20%


Growthquarterly 32.25%
Growthannually 154.74%
Key to the earnings and sales forecast charts.